Ventricular assist device implantation in a patient with systemic right ventricle and pectus excavatum

Mohammad Mostafa Ansari Ramandi; Stan A J van den Broek; Gianclaudio Mecozzi; Michiel E Erasmus; Joost P van Melle; Kevin Damman

doi:10.1016/j.jccase.2022.03.021

Ventricular assist device implantation in a patient with systemic right ventricle and pectus excavatum

J Cardiol Cases. 2022 May 2;26(2):122-125. doi: 10.1016/j.jccase.2022.03.021. eCollection 2022 Aug.

Authors

Mohammad Mostafa Ansari Ramandi¹, Stan A J van den Broek¹, Gianclaudio Mecozzi², Michiel E Erasmus², Joost P van Melle¹, Kevin Damman¹

Affiliations

¹ University of Groningen, Department of Cardiology, University Medical Center Groningen, Groningen, the Netherlands.
² University of Groningen, Department of Cardiothoracic Surgery, University Medical Center Groningen, Groningen, the Netherlands.

Abstract

Systemic right ventricular failure is a common finding in patients with transposition of the great arteries. Some of these patients require ventricular assist device implantation. We describe the feasibility of HeartMate 3 [Abbott, Illinois, United States] implantation in a patient with transposition of the great arteries, high human leukocyte antigen sensitization, and severe pectus excavatum using a two-stage approach.

Learning objectives: 1.To notice the challenges faced while implanting HeartMate 3 [Abbott, Illinois, United States] in patients with congenital heart disease and anatomical limitations.2.To understand that despite the difficulties, HeartMate 3 implantation is possible, worthwhile, and sometimes the only choice in a patient with end-stage heart failure and congenital heart disease.

Keywords: Congenital heart disease; Heart failure; HeartMate 3; TGA, Transposition of the Great Arteries; Transposition of the great arteries; VAD, Ventricular Assist Device.

Publication types

Case Reports